Top Buy
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €83.00 | €100.00 | 20.482% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €70.12 | €80.00 | 14.090% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.93 | €5.51 | 490.428% |
| Prothena Corp. plc | 12 | 0 | 0 | 0 | €22.20 | €81.43 | 266.811% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.75 | €8.75 | 12.903% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €8.61 | €11.00 | 27.818% |
| Viracta Therapeutics Inc. | 2 | 0 | 0 | 0 | €0.72 | - | - |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.36 | - | - |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.22 | €19.86 | 219.628% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.39 | €7.00 | 106.246% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Immunic Inc. | 6 | 3 | 0 | 0 | €1.26 | €5.48 | 336.102% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €20.55 | €38.19 | 85.857% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
| Chromadex Corp | 10 | 2 | 0 | 0 | €3.58 | €5.76 | 60.793% |
| Cocrystal Pharma Inc. | 6 | 0 | 0 | 0 | €1.49 | €10.08 | 576.376% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €206.00 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €353.50 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.80 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €5.15 | €5.00 | -2.913% |
| ImmunityBio Inc. | 3 | 0 | 0 | 0 | €8.01 | €10.00 | 24.813% |
| Fate Therapeutics Inc. | 5 | 2 | 0 | 0 | €3.72 | €8.27 | 122.031% |